IBDEI1R8 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29375,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,29375,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,29375,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,29376,0)
 ;;=L24.9^^135^1361^163
 ;;^UTILITY(U,$J,358.3,29376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29376,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,29376,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,29376,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,29377,0)
 ;;=L25.9^^135^1361^115
 ;;^UTILITY(U,$J,358.3,29377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29377,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,29377,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,29377,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,29378,0)
 ;;=L26.^^135^1361^148
 ;;^UTILITY(U,$J,358.3,29378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29378,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,29378,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,29378,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,29379,0)
 ;;=L27.0^^135^1361^265
 ;;^UTILITY(U,$J,358.3,29379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29379,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,29379,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,29379,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,29380,0)
 ;;=L27.1^^135^1361^266
 ;;^UTILITY(U,$J,358.3,29380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29380,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,29380,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,29380,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,29381,0)
 ;;=L29.0^^135^1361^250
 ;;^UTILITY(U,$J,358.3,29381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29381,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,29381,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,29381,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,29382,0)
 ;;=L29.9^^135^1361^251
 ;;^UTILITY(U,$J,358.3,29382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29382,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,29382,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,29382,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,29383,0)
 ;;=L30.0^^135^1361^232
 ;;^UTILITY(U,$J,358.3,29383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29383,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,29383,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,29383,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,29384,0)
 ;;=L30.1^^135^1361^140
 ;;^UTILITY(U,$J,358.3,29384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29384,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,29384,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,29384,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,29385,0)
 ;;=L30.2^^135^1361^132
 ;;^UTILITY(U,$J,358.3,29385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29385,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,29385,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,29385,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,29386,0)
 ;;=L30.4^^135^1361^144
 ;;^UTILITY(U,$J,358.3,29386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29386,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,29386,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,29386,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,29387,0)
 ;;=L30.8^^135^1361^135
 ;;^UTILITY(U,$J,358.3,29387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29387,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,29387,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,29387,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,29388,0)
 ;;=L30.9^^135^1361^136
 ;;^UTILITY(U,$J,358.3,29388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29388,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,29388,1,4,0)
 ;;=4^L30.9
